Reply

Reply

Bibliographic Details
Main Authors:	Grayson, PC, Ponte, C, Robson, JC, Suppiah, R, Judge, A, Hutchings, A, Craven, A, Khalid, S, Luqmani, RA, Watts, RA, Merkel, PA
Format:	Journal article
Language:	English
Published:	Wiley 2022

Similar Items

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis
by: Suppiah, R, et al.
Published: (2022)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
by: Ponte, C, et al.
Published: (2022)

American College of Rheumatology and European League Against Rheumatism 2017 Provisional Classification Criteria for Granulomatosis with Polyangiitis
by: Grayson, PC, et al.
Published: (2017)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
by: Ponte, C, et al.
Published: (2022)

Classification criteria for the anca-associated vasculitides
by: Robson, J, et al.
Published: (2019)

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
by: Grayson, PC, et al.
Published: (2022)

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).
by: Craven, A, et al.
Published: (2013)

Review Of The Expert Panel Methodology In The Diagnostic and Classification Criteria For Vasculitis Study: A Pilot Study
by: Ponte, C, et al.
Published: (2013)

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
by: Grayson, P, et al.
Published: (2022)

REVIEW OF THE EXPERT PANEL METHODOLOGY IN THE DIAGNOSTIC AND CLASSIFICATION CRITERIA FOR VASCULITIS STUDY: A PILOT STUDY
by: Pante, C, et al.
Published: (2014)

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?
by: Seeliger, B, et al.
Published: (2017)

276 The short-term damage burden in vasculitis and vasculitis mimics as measured by the vasculitis damage index
by: Floris, A, et al.
Published: (2016)

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
by: Luqmani, R, et al.
Published: (2011)

SY4_1 Giant cell arteritis (GCA) and Takayasu arteritis (TAK): a spectrum within the same disease or not? A report from the DCVAS project
by: Luqmani, R, et al.
Published: (2017)

FRI0312 The frequency and severity of patient-reported symptoms in giant cell arteritis
by: Monti, S, et al.
Published: (2017)

The frequency and severity of patient-reported symptoms in giant cell arteritis
by: Monti, S, et al.
Published: (2017)

THE FREQUENCY AND SEVERITY OF PATIENT-REPORTED SYMPTOMS IN GIANT CELL ARTERITIS
by: Monti, S, et al.
Published: (2017)

Reply
by: Falk, R, et al.
Published: (2011)

Reply.
by: Falk, R, et al.
Published: (2011)

O08 Blindness in patients with giant cell arteritis and its association with vascular disease
by: Yates, M, et al.
Published: (2016)

Systemic vasculitis--is it time to reclassify?
by: Watts, R, et al.
Published: (2011)

Association between age at diagnosis and clinical presentation and outcomes of anca-associated vasculitis. analysis from the dcvas study
by: Monti, S, et al.
Published: (2018)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
by: Pearce, F, et al.
Published: (2017)

Global ethnic and geographic idfferences in the clinical features of ANCA-associated vasculitis
by: Pearce, F, et al.
Published: (2016)

The association of vascular risk factors with visual loss in giant cell arteritis
by: Yates, M, et al.
Published: (2016)

Pulmonary manifestations of primary systemic vasculitides
by: Makhzoum, J, et al.
Published: (2017)

284 Differences in early damage patterns in various forms of primary systemic vasculitis
by: Wawrzycka-Adamczyk, K, et al.
Published: (2016)

Cutaneous manifestations of ANCA-associated vasculitis
by: Chiesafuxench, Z, et al.
Published: (2016)

Cutaneous manifestations of ANCA-associated vasculitis are common, varied, and associated with systemic disease
by: Micheletti, R, et al.
Published: (2017)

Outcome measures in ANCA-associated vasculitis.
by: Suppiah, R, et al.
Published: (2010)

Advances in the classification of primary systemic vasculitis
by: Suppiah, R, et al.
Published: (2009)

The need for diagnostic criteria in systemic vasculitis
by: Suppiah, R, et al.
Published: (2011)

Tumor necrosis factor-blocking agents in polymyalgia rheumatica and giant cell arteritis - Reply
by: Luqmani, R
Published: (2008)

Prevalence and associations of peripheral neuropathy at disease-onset in ANCA-associated vasculitides: Data from DCVAS study
by: Michael, C, et al.
Published: (2018)

THU0306 Prevalence and characteristics of neuropathy in patients with ANCA associated vasculitides: data from the DCVAS study
by: Bischof, A, et al.
Published: (2017)

THU0297 A novel ultrasound scoring system for giant cell arteritis
by: Monti, S, et al.
Published: (2017)

Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study
by: Geraldes, R, et al.
Published: (2024)

P1_41 Histology findings in giant cell arteritis (GCA) and their relationship with the ultrasound results: analysis of data from the TABUL study (Temporal Artery Biopsy vs Ultrasound in diagnosis of Giant Cell Arteritis)
by: Ponte, C, et al.
Published: (2017)

THU0302 Histology findings in giant cell arteritis (GCA) and their relationship with the ultrasound results: analysis of data from the tabul study (temporal artery biopsy vs ultrasound in diagnosis of giant cell arteritis)
by: Ponte, C, et al.
Published: (2017)

The authors reply
by: Chapman, D, et al.
Published: (2023)